Search

Home > The Bio Report > Rewriting Drug Discovery with an AI-Multi-Omics Approach
Podcast: The Bio Report
Episode:

Rewriting Drug Discovery with an AI-Multi-Omics Approach

Category: Business
Duration: 00:45:49
Publish Date: 2025-11-26 08:00:00
Description:

The genomics revolution promised to unravel diseases and lead to treatments that addressed their root causes. In reality, says Mo Jain, your zip code remains a better predictor for how healthy you will be over the course of your life than your genetic code does. That’s because, except for monogenic diseases, etiology tends to be far more complex than the identification of a single gene. Sapient Bio company is using its AI-driven, multi-omics platform to advance the discovery and development of precision medicines. We spoke to Jain, chief scientific officer of Sapient, about how its technology bridges the gap from discovery to clinical development, accelerates drug development timelines, and expands opportunities to drug previously undruggable targets.

Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes